PENTAIR ($PNR) posted quarterly earnings results for Q4 2025 on Tuesday, February 3rd. The company reported earnings of $1.18 per share, beating estimates of $1.17 by $0.01. The company also reported revenue of $1,020,500,000, beating estimates of $1,019,030,187 by $1,469,813.
You can see Quiver Quantitative's $PNR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PENTAIR Insider Trading Activity
PENTAIR insiders have traded $PNR stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $PNR stock by insiders over the last 6 months:
- ROBERT P FISHMAN (EVP & Chief Financial Officer) has made 0 purchases and 8 sales selling 7,786 shares for an estimated $820,765.
- T MICHAEL GLENN sold 6,558 shares for an estimated $684,196
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PENTAIR Hedge Fund Activity
We have seen 354 institutional investors add shares of PENTAIR stock to their portfolio, and 352 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 5,525,601 shares (+262.8%) to their portfolio in Q3 2025, for an estimated $612,015,566
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,577,036 shares (+65.3%) to their portfolio in Q3 2025, for an estimated $285,432,507
- BLACKROCK, INC. removed 1,741,567 shares (-10.2%) from their portfolio in Q3 2025, for an estimated $192,895,960
- AMERIPRISE FINANCIAL INC added 1,670,944 shares (+106.7%) to their portfolio in Q3 2025, for an estimated $185,073,757
- ALLIANCEBERNSTEIN L.P. removed 1,217,896 shares (-46.6%) from their portfolio in Q3 2025, for an estimated $134,894,160
- VALEO FINANCIAL ADVISORS, LLC removed 1,000,910 shares (-99.8%) from their portfolio in Q3 2025, for an estimated $110,860,791
- ALYESKA INVESTMENT GROUP, L.P. removed 738,358 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $81,780,532
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PENTAIR Congressional Stock Trading
Members of Congress have traded $PNR stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PNR stock by members of Congress over the last 6 months:
- SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 11/10.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PENTAIR Analyst Ratings
Wall Street analysts have issued reports on $PNR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/12/2026
- BNP Paribas Exane issued a "Underperform" rating on 01/07/2026
- UBS issued a "Buy" rating on 10/22/2025
- RBC Capital issued a "Outperform" rating on 10/22/2025
- JP Morgan issued a "Overweight" rating on 10/15/2025
To track analyst ratings and price targets for PENTAIR, check out Quiver Quantitative's $PNR forecast page.
PENTAIR Price Targets
Multiple analysts have issued price targets for $PNR recently. We have seen 8 analysts offer price targets for $PNR in the last 6 months, with a median target of $124.0.
Here are some recent targets:
- Stephen Tusa from JP Morgan set a target price of $124.0 on 01/16/2026
- Andrew Kaplowitz from Citigroup set a target price of $126.0 on 01/12/2026
- Joseph Giordano from TD Cowen set a target price of $90.0 on 01/05/2026
- Saree Boroditsky from Jefferies set a target price of $135.0 on 12/10/2025
- Julian Mitchell from Barclays set a target price of $115.0 on 12/04/2025
- Bryan Blair from Oppenheimer set a target price of $128.0 on 11/20/2025
- Deane Dray from RBC Capital set a target price of $124.0 on 10/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
